Acquired Company
Alexion, AstraZeneca Rare Disease completed the acquisition of LogicBio Therapeutics, Inc. on November 16, 2022.
ContextLogic Holdings Inc. focuses on seeking to develop and grow a de novo business and finance potential future bolt-on acquisitions of assets or businesses. The company was incorporated in 2010 and is headquartered in Oakland, California. Show more
Location: 2648 International Blvd., 2Nd Floor, Oakland, CA, 94601, United States | Website: https://ir.contextlogicinc.com | Industry: Internet Retail | Sector: Consumer Cyclical
Market Cap
211.1M
52 Wk Range
$6.15 - $9.34
Previous Close
$7.90
Open
$7.92
Volume
292,367
Day Range
$7.80 - $7.95
Enterprise Value
62.1M
Cash
218M
Avg Qtr Burn
-4.00M
Insider Ownership
2.53%
Institutional Own.
14.41%
Qtr Updated
09/30/25
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|